Global Coagulation Factor VIIa Market Growth 2022-2028
- LP 4871176
- 76 Pages
- February 2022
- Pharmaceuticals
The United States Coagulation Factor VIIa market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Coagulation Factor VIIa market, reaching US$ million by the year 2028. As for the Europe Coagulation Factor VIIa landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Coagulation Factor VIIa players cover Novo Nordisk, , , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Coagulation Factor VIIa market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
NovoSeven
NovoSevenRT
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Pharmacy
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Novo Nordisk
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Coagulation Factor VIIa Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Coagulation Factor VIIa by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Coagulation Factor VIIa by Country/Region, 2017, 2022 & 2028
2.2 Coagulation Factor VIIa Segment by Type
2.2.1 NovoSeven
2.2.2 NovoSevenRT
2.3 Coagulation Factor VIIa Sales by Type
2.3.1 Global Coagulation Factor VIIa Sales Market Share by Type (2017-2022)
2.3.2 Global Coagulation Factor VIIa Revenue and Market Share by Type (2017-2022)
2.3.3 Global Coagulation Factor VIIa Sale Price by Type (2017-2022)
2.4 Coagulation Factor VIIa Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.5 Coagulation Factor VIIa Sales by Application
2.5.1 Global Coagulation Factor VIIa Sale Market Share by Application (2017-2022)
2.5.2 Global Coagulation Factor VIIa Revenue and Market Share by Application (2017-2022)
2.5.3 Global Coagulation Factor VIIa Sale Price by Application (2017-2022)
3 Global Coagulation Factor VIIa by Company
3.1 Global Coagulation Factor VIIa Breakdown Data by Company
3.1.1 Global Coagulation Factor VIIa Annual Sales by Company (2020-2022)
3.1.2 Global Coagulation Factor VIIa Sales Market Share by Company (2020-2022)
3.2 Global Coagulation Factor VIIa Annual Revenue by Company (2020-2022)
3.2.1 Global Coagulation Factor VIIa Revenue by Company (2020-2022)
3.2.2 Global Coagulation Factor VIIa Revenue Market Share by Company (2020-2022)
3.3 Global Coagulation Factor VIIa Sale Price by Company
3.4 Key Manufacturers Coagulation Factor VIIa Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Coagulation Factor VIIa Product Location Distribution
3.4.2 Players Coagulation Factor VIIa Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Coagulation Factor VIIa by Geographic Region
4.1 World Historic Coagulation Factor VIIa Market Size by Geographic Region (2017-2022)
4.1.1 Global Coagulation Factor VIIa Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Coagulation Factor VIIa Annual Revenue by Geographic Region
4.2 World Historic Coagulation Factor VIIa Market Size by Country/Region (2017-2022)
4.2.1 Global Coagulation Factor VIIa Annual Sales by Country/Region (2017-2022)
4.2.2 Global Coagulation Factor VIIa Annual Revenue by Country/Region
4.3 Americas Coagulation Factor VIIa Sales Growth
4.4 APAC Coagulation Factor VIIa Sales Growth
4.5 Europe Coagulation Factor VIIa Sales Growth
4.6 Middle East & Africa Coagulation Factor VIIa Sales Growth
5 Americas
5.1 Americas Coagulation Factor VIIa Sales by Country
5.1.1 Americas Coagulation Factor VIIa Sales by Country (2017-2022)
5.1.2 Americas Coagulation Factor VIIa Revenue by Country (2017-2022)
5.2 Americas Coagulation Factor VIIa Sales by Type
5.3 Americas Coagulation Factor VIIa Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Coagulation Factor VIIa Sales by Region
6.1.1 APAC Coagulation Factor VIIa Sales by Region (2017-2022)
6.1.2 APAC Coagulation Factor VIIa Revenue by Region (2017-2022)
6.2 APAC Coagulation Factor VIIa Sales by Type
6.3 APAC Coagulation Factor VIIa Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Coagulation Factor VIIa by Country
7.1.1 Europe Coagulation Factor VIIa Sales by Country (2017-2022)
7.1.2 Europe Coagulation Factor VIIa Revenue by Country (2017-2022)
7.2 Europe Coagulation Factor VIIa Sales by Type
7.3 Europe Coagulation Factor VIIa Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Coagulation Factor VIIa by Country
8.1.1 Middle East & Africa Coagulation Factor VIIa Sales by Country (2017-2022)
8.1.2 Middle East & Africa Coagulation Factor VIIa Revenue by Country (2017-2022)
8.2 Middle East & Africa Coagulation Factor VIIa Sales by Type
8.3 Middle East & Africa Coagulation Factor VIIa Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Coagulation Factor VIIa
10.3 Manufacturing Process Analysis of Coagulation Factor VIIa
10.4 Industry Chain Structure of Coagulation Factor VIIa
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Coagulation Factor VIIa Distributors
11.3 Coagulation Factor VIIa Customer
12 World Forecast Review for Coagulation Factor VIIa by Geographic Region
12.1 Global Coagulation Factor VIIa Market Size Forecast by Region
12.1.1 Global Coagulation Factor VIIa Forecast by Region (2023-2028)
12.1.2 Global Coagulation Factor VIIa Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Coagulation Factor VIIa Forecast by Type
12.7 Global Coagulation Factor VIIa Forecast by Application
13 Key Players Analysis
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk Coagulation Factor VIIa Product Offered
13.1.3 Novo Nordisk Coagulation Factor VIIa Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
14 Research Findings and Conclusion
Table 1. Coagulation Factor VIIa Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Coagulation Factor VIIa Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of NovoSeven
Table 4. Major Players of NovoSevenRT
Table 5. Global Coagulation Factor VIIa Sales by Type (2017-2022) & (MT)
Table 6. Global Coagulation Factor VIIa Sales Market Share by Type (2017-2022)
Table 7. Global Coagulation Factor VIIa Revenue by Type (2017-2022) & ($ million)
Table 8. Global Coagulation Factor VIIa Revenue Market Share by Type (2017-2022)
Table 9. Global Coagulation Factor VIIa Sale Price by Type (2017-2022) & (USD/Kg)
Table 10. Global Coagulation Factor VIIa Sales by Application (2017-2022) & (MT)
Table 11. Global Coagulation Factor VIIa Sales Market Share by Application (2017-2022)
Table 12. Global Coagulation Factor VIIa Revenue by Application (2017-2022)
Table 13. Global Coagulation Factor VIIa Revenue Market Share by Application (2017-2022)
Table 14. Global Coagulation Factor VIIa Sale Price by Application (2017-2022) & (USD/Kg)
Table 15. Global Coagulation Factor VIIa Sales by Company (2020-2022) & (MT)
Table 16. Global Coagulation Factor VIIa Sales Market Share by Company (2020-2022)
Table 17. Global Coagulation Factor VIIa Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Coagulation Factor VIIa Revenue Market Share by Company (2020-2022)
Table 19. Global Coagulation Factor VIIa Sale Price by Company (2020-2022) & (USD/Kg)
Table 20. Key Manufacturers Coagulation Factor VIIa Producing Area Distribution and Sales Area
Table 21. Players Coagulation Factor VIIa Products Offered
Table 22. Coagulation Factor VIIa Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Coagulation Factor VIIa Sales by Geographic Region (2017-2022) & (MT)
Table 26. Global Coagulation Factor VIIa Sales Market Share Geographic Region (2017-2022)
Table 27. Global Coagulation Factor VIIa Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Coagulation Factor VIIa Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Coagulation Factor VIIa Sales by Country/Region (2017-2022) & (MT)
Table 30. Global Coagulation Factor VIIa Sales Market Share by Country/Region (2017-2022)
Table 31. Global Coagulation Factor VIIa Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Coagulation Factor VIIa Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Coagulation Factor VIIa Sales by Country (2017-2022) & (MT)
Table 34. Americas Coagulation Factor VIIa Sales Market Share by Country (2017-2022)
Table 35. Americas Coagulation Factor VIIa Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Coagulation Factor VIIa Revenue Market Share by Country (2017-2022)
Table 37. Americas Coagulation Factor VIIa Sales by Type (2017-2022) & (MT)
Table 38. Americas Coagulation Factor VIIa Sales Market Share by Type (2017-2022)
Table 39. Americas Coagulation Factor VIIa Sales by Application (2017-2022) & (MT)
Table 40. Americas Coagulation Factor VIIa Sales Market Share by Application (2017-2022)
Table 41. APAC Coagulation Factor VIIa Sales by Region (2017-2022) & (MT)
Table 42. APAC Coagulation Factor VIIa Sales Market Share by Region (2017-2022)
Table 43. APAC Coagulation Factor VIIa Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Coagulation Factor VIIa Revenue Market Share by Region (2017-2022)
Table 45. APAC Coagulation Factor VIIa Sales by Type (2017-2022) & (MT)
Table 46. APAC Coagulation Factor VIIa Sales Market Share by Type (2017-2022)
Table 47. APAC Coagulation Factor VIIa Sales by Application (2017-2022) & (MT)
Table 48. APAC Coagulation Factor VIIa Sales Market Share by Application (2017-2022)
Table 49. Europe Coagulation Factor VIIa Sales by Country (2017-2022) & (MT)
Table 50. Europe Coagulation Factor VIIa Sales Market Share by Country (2017-2022)
Table 51. Europe Coagulation Factor VIIa Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Coagulation Factor VIIa Revenue Market Share by Country (2017-2022)
Table 53. Europe Coagulation Factor VIIa Sales by Type (2017-2022) & (MT)
Table 54. Europe Coagulation Factor VIIa Sales Market Share by Type (2017-2022)
Table 55. Europe Coagulation Factor VIIa Sales by Application (2017-2022) & (MT)
Table 56. Europe Coagulation Factor VIIa Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Coagulation Factor VIIa Sales by Country (2017-2022) & (MT)
Table 58. Middle East & Africa Coagulation Factor VIIa Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Coagulation Factor VIIa Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Coagulation Factor VIIa Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Coagulation Factor VIIa Sales by Type (2017-2022) & (MT)
Table 62. Middle East & Africa Coagulation Factor VIIa Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Coagulation Factor VIIa Sales by Application (2017-2022) & (MT)
Table 64. Middle East & Africa Coagulation Factor VIIa Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Coagulation Factor VIIa
Table 66. Key Market Challenges & Risks of Coagulation Factor VIIa
Table 67. Key Industry Trends of Coagulation Factor VIIa
Table 68. Coagulation Factor VIIa Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Coagulation Factor VIIa Distributors List
Table 71. Coagulation Factor VIIa Customer List
Table 72. Global Coagulation Factor VIIa Sales Forecast by Region (2023-2028) & (MT)
Table 73. Global Coagulation Factor VIIa Sales Market Forecast by Region
Table 74. Global Coagulation Factor VIIa Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Coagulation Factor VIIa Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Coagulation Factor VIIa Sales Forecast by Country (2023-2028) & (MT)
Table 77. Americas Coagulation Factor VIIa Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Coagulation Factor VIIa Sales Forecast by Region (2023-2028) & (MT)
Table 79. APAC Coagulation Factor VIIa Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Coagulation Factor VIIa Sales Forecast by Country (2023-2028) & (MT)
Table 81. Europe Coagulation Factor VIIa Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Coagulation Factor VIIa Sales Forecast by Country (2023-2028) & (MT)
Table 83. Middle East & Africa Coagulation Factor VIIa Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Coagulation Factor VIIa Sales Forecast by Type (2023-2028) & (MT)
Table 85. Global Coagulation Factor VIIa Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Coagulation Factor VIIa Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Coagulation Factor VIIa Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Coagulation Factor VIIa Sales Forecast by Application (2023-2028) & (MT)
Table 89. Global Coagulation Factor VIIa Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Coagulation Factor VIIa Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Coagulation Factor VIIa Revenue Market Share Forecast by Application (2023-2028)
Table 92. Novo Nordisk Basic Information, Coagulation Factor VIIa Manufacturing Base, Sales Area and Its Competitors
Table 93. Novo Nordisk Coagulation Factor VIIa Product Offered
Table 94. Novo Nordisk Coagulation Factor VIIa Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 95. Novo Nordisk Main Business
Table 96. Novo Nordisk Latest Developments
List of Figures
Figure 1. Picture of Coagulation Factor VIIa
Figure 2. Coagulation Factor VIIa Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Coagulation Factor VIIa Sales Growth Rate 2017-2028 (MT)
Figure 7. Global Coagulation Factor VIIa Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Coagulation Factor VIIa Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of NovoSeven
Figure 10. Product Picture of NovoSevenRT
Figure 11. Global Coagulation Factor VIIa Sales Market Share by Type in 2021
Figure 12. Global Coagulation Factor VIIa Revenue Market Share by Type (2017-2022)
Figure 13. Coagulation Factor VIIa Consumed in Hospital
Figure 14. Global Coagulation Factor VIIa Market: Hospital (2017-2022) & (MT)
Figure 15. Coagulation Factor VIIa Consumed in Pharmacy
Figure 16. Global Coagulation Factor VIIa Market: Pharmacy (2017-2022) & (MT)
Figure 17. Global Coagulation Factor VIIa Sales Market Share by Application (2017-2022)
Figure 18. Global Coagulation Factor VIIa Revenue Market Share by Application in 2021
Figure 19. Coagulation Factor VIIa Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Coagulation Factor VIIa Revenue Market Share by Company in 2021
Figure 21. Global Coagulation Factor VIIa Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Coagulation Factor VIIa Revenue Market Share by Geographic Region in 2021
Figure 23. Global Coagulation Factor VIIa Sales Market Share by Region (2017-2022)
Figure 24. Global Coagulation Factor VIIa Revenue Market Share by Country/Region in 2021
Figure 25. Americas Coagulation Factor VIIa Sales 2017-2022 (MT)
Figure 26. Americas Coagulation Factor VIIa Revenue 2017-2022 ($ Millions)
Figure 27. APAC Coagulation Factor VIIa Sales 2017-2022 (MT)
Figure 28. APAC Coagulation Factor VIIa Revenue 2017-2022 ($ Millions)
Figure 29. Europe Coagulation Factor VIIa Sales 2017-2022 (MT)
Figure 30. Europe Coagulation Factor VIIa Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Coagulation Factor VIIa Sales 2017-2022 (MT)
Figure 32. Middle East & Africa Coagulation Factor VIIa Revenue 2017-2022 ($ Millions)
Figure 33. Americas Coagulation Factor VIIa Sales Market Share by Country in 2021
Figure 34. Americas Coagulation Factor VIIa Revenue Market Share by Country in 2021
Figure 35. United States Coagulation Factor VIIa Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Coagulation Factor VIIa Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Coagulation Factor VIIa Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Coagulation Factor VIIa Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Coagulation Factor VIIa Sales Market Share by Region in 2021
Figure 40. APAC Coagulation Factor VIIa Revenue Market Share by Regions in 2021
Figure 41. China Coagulation Factor VIIa Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Coagulation Factor VIIa Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Coagulation Factor VIIa Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Coagulation Factor VIIa Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Coagulation Factor VIIa Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Coagulation Factor VIIa Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Coagulation Factor VIIa Sales Market Share by Country in 2021
Figure 48. Europe Coagulation Factor VIIa Revenue Market Share by Country in 2021
Figure 49. Germany Coagulation Factor VIIa Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Coagulation Factor VIIa Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Coagulation Factor VIIa Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Coagulation Factor VIIa Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Coagulation Factor VIIa Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Coagulation Factor VIIa Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Coagulation Factor VIIa Revenue Market Share by Country in 2021
Figure 56. Egypt Coagulation Factor VIIa Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Coagulation Factor VIIa Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Coagulation Factor VIIa Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Coagulation Factor VIIa Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Coagulation Factor VIIa Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Coagulation Factor VIIa in 2021
Figure 62. Manufacturing Process Analysis of Coagulation Factor VIIa
Figure 63. Industry Chain Structure of Coagulation Factor VIIa
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
